Skip to main content

Clifford Chance

News and awards

Clifford Chance advises on Hansoh Pharmaceutical's US$1 billion IPO

  • en
  • zh
  • Language options

14 June 2019

Clifford Chance advises on Hansoh Pharmaceutical's US$1 billion IPO

Leading international law firm Clifford Chance continues to advise on the most significant Hong Kong initial public offerings, with a cross-border team in Hong Kong, Beijing and Shanghai advising on two recent listings on the Hong Kong Stock Exchange.

The firm advised the underwriters led by Morgan Stanley, Citi, UBS, Goldman Sachs and China Merchant Securities as the Joint Global Coordinators on Hansoh Pharmaceutical's HK$7.9 billion (US$1 billion) listing, the second biggest in Hong Kong so far this year.

Partner Amy Lo led the cross-border team, with China Co-Managing Partner Tim Wang and partners Jean Thio, Liu Fang and Christine Xu. They were supported by a team consisting of counsel Hao Wu, senior associates Claire Cao, Sheng Chen and Queenie Tong, and associates Helen Huang and Emma Bao.

The firm also advised Haitong International Capital Limited, China International Capital Corporation Hong Kong Securities Limited, Citigroup Global Markets Asia Limited, and CMB International Capital Limited as the joint sponsors of the HK$2.3 billion (US$296 million) listing of financial leasing company Haitong UniTrust International Leasing Co., Ltd.

China Co-Managing Partner Tim Wang led on the deal, with partners Jean Thio and Virginia Lee. The team includes counsel Lorna Lyu, senior associate Janet Tang and associates Xuemei Wang and Emma Bao.

高伟绅为翰森制药10亿美元的香港首次公开发行提供法律服务

领先国际律师事务所高伟绅就翰森制药集团有限公司10亿美元(79亿港元)的香港首次公开发行项目,为由摩根士丹利、花旗、瑞银、高盛和招商证券作为联席全球协调人带领的承销商团队提供法律服务。这是截至目前2019年香港第二大的首次公开发行项目。

本项目由合伙人罗秀娴律师领导,中国区联席管理合伙人王彦峰律师、合伙人张珮真律师、方刘律师以及许文嘉律师亦提供支持。此外,该项目的律师团队还包括吴皓曹阳陈盛唐嘉雯黄海伦包宸

此外,高伟绅上周还就海通恒信国际租赁股份有限公司的2.96亿美元(23亿港元)的上市项目,为包括海通国际、中金香港、花旗和招银国际在内的联席保荐人提供法律服务。

该项目由中国联席管理合伙人王彦峰律师与合伙人张珮真律师和李婉雯律师共同领导,并由包括吕娜邓敏蔚王雪梅包宸在内的律师团队提供支持。